JUNYA KURODA

Has grant

Professor

Kyoto Prefectural University of Medicine

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Junya Kuroda is a Professor at Kyoto Prefectural University of Medicine, Japan. His research primarily focuses on hematological malignancies, with recent publications investigating therapies for follicular lymphoma and multiple myeloma. He has contributed to the understanding of treatment efficacy, risk factors for disease progression, and the impact of immunological responses in patients. His work includes multicenter studies and assessments of novel agents in managing complex hematologic conditions.

Recent Grants

Grant: Close

Drug discovery targeted against RSK2 in multiple myeloma

Open Date: 2019-04-01

Close Date: 2022-03-31

Grant: Close

The functional involvement of PDPK1 in the pathophysiology of multiple myeloma

Open Date: 2014-04-01

Close Date: 2017-03-31

Grant: Close

The mechanism of autocrine and paracrine growth promotion of CML cells

Open Date: 2013-04-01

Close Date: 2015-03-31

Grant: Close

Molecular and cellular effects of tumor microenvironment-specific Galectin-3 in leukemia

Open Date: 2011-01-01

Close Date: 2013-12-31

Grant: Close

Drug resistance mediated by hypoxic bone marrow leukemia environment in chronic myelogenous leukemia

Open Date: 2007-01-01

Close Date: 2008-12-31

Articles (20)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

JAPAN

View details

Koichi Takayama

Professor

Kyoto Prefectural University of Medicine

JAPAN

View details

Akihiro Miyashita

University of Hawaii

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

JUNYA KURODA

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

PI3Kδ Inhibitor Parsaclisib in Japanese Patients With Relapsed or Refractory Follicular Lymphoma

Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016–2021)

A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan

Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203

Autologous HSCT with novel agent-based induction and consolidation followed by lenalidomide maintenance for untreated multiple myeloma

Clinical impacts of severe thrombocytopenia in the first cycle of azacitidine monotherapy and cytogenetics in patients with myelodysplastic syndrome: The Kyoto Conditional Survival Scoring System

Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study

Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results

Negative impact of immunoparesis in response to anti-SARS-CoV-2 mRNA vaccination of patients with multiple myeloma

Nirmatrelvir Resistance in an Immunocompromised Patient with Persistent Coronavirus Disease 2019

Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia

Neurolymphomatosis of cranial nerves as the responsible lesions for the vocal cord paralysis and facial nerve palsy in a patient with diffuse large B-cell lymphoma

Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort

Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105)

Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial

Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia

Expression of activated B-cell gene signature is predictive of the outcome of follicular lymphoma

The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma

Combination of Bone Marrow Biopsy and Flow Cytometric Analysis: The Prognostically Relevant Central Approach for Detecting Bone Marrow Invasion in Diffuse Large B-Cell Lymphoma

Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105)

Collaborators (7)

Hirohiko Shibayama

Takahiro Maeda

Nobuhiko Yamauchi

Junya Kanda

Seiichiro Katagiri

Koichi Takayama

Akihiro Miyashita

Make your next move.